Exact Sciences Secures All Regulatory Approvals for Abbott Merger, Anticipates March 23 Close

summarizeSummary

Exact Sciences announced it has received all necessary regulatory approvals for its merger with Abbott Laboratories, with the transaction now expected to close on March 23, 2026.

check_boxKey Events

• Regulatory Approvals Secured

  Exact Sciences and Abbott Laboratories have received all required regulatory approvals and clearances for their merger as of March 19, 2026.

• Merger Closing Imminent

  The merger is now anticipated to close on March 23, 2026, subject to the satisfaction or waiver of remaining conditions.

• Prior Shareholder Approval

  Exact Sciences' stockholders previously approved the merger at a special meeting on February 20, 2026.

auto_awesomeAnalysis

This 8-K provides a critical update on the previously announced merger with Abbott Laboratories. The confirmation that all regulatory approvals and clearances have been secured significantly de-risks the transaction and makes the anticipated closing on March 23, 2026, highly probable. This positive development removes a major uncertainty for investors regarding the acquisition, which was first disclosed in the company's 10-K filing on February 13, 2026. The successful completion of this merger will fundamentally alter Exact Sciences' corporate structure and strategic direction.